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Abstract  Whenever  several  therapeutic  options  exist,  multidisciplinary  decision-making  is
beneficial for  the  patient  and  for  society  at  large.  The  main  obstacles  to  the  establishment  of
heart teams  in  Portugal  are  organizational  and  logistical.  Implementing  a  heart  team  approach
entails definition  of  the  situations  requiring  multidisciplinary  discussion,  creation  of  clear  lines
of communication,  written  protocols  and  obtaining  patient  informed  consent.  The  European
Society  of  Cardiology  guidelines  define  the  clinical  scenarios  where  intervention  of  the  heart
team is  recommended.
© 2013  Sociedade  Portuguesa  de  Cardiologia  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
PALAVRAS-CHAVE
Equipa
multidisciplinar;
Operacionalizac¸ão  do  Heart  Team  em  Portugal
Resumo  A  decisão  médica  tomada  em  equipas  multidisciplinares  é  uma  mais-valia  indiscutível
Processo  de  decisão; para o  doente  e  para  a  sociedade,  particularmente  quando  existem  várias  opc¸ões  terapêuticas.
Normas  de  orientac¸ão
clínicas;
Recomendac¸ões;
Informac¸ão  do  doente
A falta  de  disponibilidade  dos  intervenientes,  problemas  logísticos  e  barreiras  interdisciplinares
são alguns  dos  obstáculos  à  operacionalizac¸ão  do  Heart  Team  em  Portugal.  A  operacionalizac¸ão
passa pela  definic¸ão  das  situac¸ões  que  necessitam  discussão  multidisciplinar,  a  elaborac¸ão
de protocolos  escritos,  a  criac¸ão  de  vias  de  comunicac¸ão  claras,  a  consignac¸ão  das  decisões
tomadas  e  a  informac¸ão  fornecida  ao  doente.  As  situac¸ões,  na  doenc¸a  coronária  e  na  doenc¸a
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valvular,  que  requerem  a  intervenc¸ão  do  Heart  Team  estão  definidas  nas  recomendac¸ões  da
Sociedade Europeia  de  Cardiologia.
© 2013  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
direitos reservados.
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mhy establish heart teams?
henever  several  therapeutic  options  exist,  multidisci-
linary  decision-making  is  beneficial  for  the  patient  and  for
ociety  at  large,  as  it  enables  their  risks  and  benefits  to
e  assessed  more  accurately  in  the  light  of  the  individual
atient’s  specific  clinical  characteristics.  The  most  com-
only  cited  example  is  in  oncology,  in  which  radiotherapy,
urgery  and  chemotherapy  are  complementary  treatments
hat  require  multidisciplinary  discussion.  There  is  evidence
hat  multidisciplinary  decision-making  in  the  diagnosis  and
reatment  of  cancer  promotes  improved  survival,  reduced
ariation  in  survival  rates  between  hospitals  and  better
dherence  to  guidelines.1
Treatment  of  cardiovascular  disease  should  be  no  differ-
nt,  since  there  are  clear  advantages  to  multidisciplinary
ecision-making  in  certain  situations,  including  heart  fail-
re,  complex  coronary  artery  disease  and  severe  aortic
tenosis  in  patients  with  high  surgical  risk.
Albeit  only  with  level  of  evidence  C,  the  European  Soci-
ty  of  Cardiology  (ESC)  guidelines  contain  various  class  I
ecommendations  on  the  need  for  therapeutic  decisions  to
e  taken  by  multidisciplinary  teams  when  assessing  non-
ardiac  surgical  risk,  and  when  choosing  the  method  of
oronary  revascularization  (percutaneous  coronary  inter-
ention  [PCI]  or  coronary  artery  bypass  grafting  [CABG])
nd  valve  replacement  in  aortic  stenosis  (surgical  or  trans-
atheter  aortic  valve  implantation  [TAVI]).2--4 Following  the
uropean  example,  the  2011  American  College  of  Cardiol-
gy  Foundation/American  Heart  Association  guidelines5 also
ontain  a  class  I  recommendation  that  decisions  for  the
reatment  of  coronary  artery  disease  should  be  taken  by  a
eart  team,  a  condition  of  reimbursement  by  the  American
ederal  authorities.6
A  heart  team  consists  of  at  least  a  clinical  cardiologist,
n  interventional  cardiologist  and  a  cardiac  surgeon,  but
an  also  include  specialists  in  cardiac  imaging,  neurology,
ephrology,  pulmonology  and  anesthesiology,  among  others.
The  rationale  behind  establishing  heart  teams  in  Portu-
al  is  that  they  are  better  equipped  to  assess  the  clinical
ituation,  taking  account  of  the  patient’s  preferences,  and
o  arrive  at  the  best  treatment  approach  through  shared
ecision-making.  As  mentioned  above,  this  process  also
mproves  adherence  to  guidelines  and  reduces  variability  in
atient  care.7,8
ow to establish heart teams?bstacles
here  are  no  published  studies  on  the  establishment  of
eart  teams  in  Portugal,  but  informal  analyses  indicate  that
m
c
c
Dultidisciplinary  teams  in  cardiology  are  uncommon,  unlike
n  oncology.  This  leads  to  lower  quality  health  care,  consid-
rable  regional  variability  in  treatment  and  possibly  higher
osts.
Several  obstacles  have  been  suggested,  including  organi-
ational  and  logistical  problems,  interdisciplinary  barriers,
ersonal  conflicts,  failure  to  recognize  the  limitations  of
roposed  treatments,  and  interests  other  than  those  of
he  patient.9--11 The  information  given  to  patients  differs
epending  on  whether  it  is  supplied  by  an  interventional
ardiologist  or  a surgeon.  A  recent  study  in  the  USA  showed
hat  the  guidelines  for  treatment  of  stable  coronary  artery
isease  were  not  followed  in  a  high  percentage  of  cases,  par-
icularly  when  CABG  was  indicated,  which  was  performed
n  only  53%,  with  34%  undergoing  PCI.12 When  patients  are
aced  with  making  a decision,  they  should  be  informed  of  the
vailable  options  and  have  the  possibility  of  discussing  the
dvantages  and  disadvantages  of  each  proposed  method  and
he  right  to  see  their  wishes  reflected  in  the  final  decision.
owever,  in  practice,  cardiovascular  patients,  unlike  can-
er  patients,  are  not  always  adequately  informed  concerning
he  various  treatment  options.13
easures required
he  first  step  in  establishing  heart  teams  is  to  prepare  writ-
en  protocols,  local  or  preferably  national,  that  define  which
ituations  require  multidisciplinary  discussion.  These  proto-
ols  should  be  supported  by  decision  tree  algorithms  that
implify  and  clarify  the  approach  to  adopt,  and  can  be
odified  by  prior  agreement  between  team  members,  as
stablished  in  the  heart  team  protocol  (Figures  1  and  2).
Implementing  a  heart  team  approach  also  requires  that
lear  lines  of  communication  be  established  between  the
arious  specialists  (who  to  contact,  when  and  how)  and
etween  the  specialists  and  physicians  outside  the  insti-
ution,  with  alternative  means  when  necessary.  The  heart
eam  can  function  in  an  informal  manner  with  discussions
aking  place  remotely,  in  the  catheterization  laboratory  or
t  the  patient’s  bedside,  or  formally,  in  regular  medical
nd  surgical  evaluations  for  complex  elective  cases.  The
ack  of  a  cardiac  surgery  department  is  not  an  obstacle
o  consultation  and  discussion,  since  information  can  be
hared  electronically  (WebEx  meetings,  image  transmission,
eleconferencing),  as  long  as  these  means  of  communica-
ion  have  been  established  and  tested.  The  most  important
lements  in  a  heart  team  are  mutual  trust  and  commit-
ent  on  the  part  of  all  members  to  work  as  a  group.  All
embers  must  actively  participate,  in  a  climate  of  interdis-
iplinary  respect  and  openness,  with  clear  acceptance  of  all
ontributions  and  of  both  positive  and  negative  reactions.
ecision-making  should  be  based  on  three  key  points:  (1)
Heart  team  implementation  in  Portugal  
Number of coronary arte ries with relevant stenosis  in proximal segment
 
1- or 2-vessel disease
Proximal LAD invol vement 
No  Yes 
PCI CABG
Low
surgical
risk*
Syntax score ≤22
Heart team discussion°
Syntax score ≥23
3-vessel disease
Figure  1  Percutaneous  coronary  intervention  or  coronary
artery bypass  grafting  in  stable  coronary  artery  disease  without
left main  stenosis.  *  Multidisciplinary  discussion  preferable,  but
direct  decision-making  possible  in  predefined  situations  estab-
lished in  the  local  protocol  by  the  heart  team.  CABG:  coronary
artery  bypass  grafting;  LAD:  left  anterior  descending;  PCI:  per-
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tcutaneous  coronary  intervention.  Reproduced  with  permission
from the  2013  ESC  Guidelines  on  Management  of  Stable  Angina.
knowledge  transfer;  (2)  discussion;  and  (3)  reaching  agree-
ment  on  the  approach  to  adopt,  in  which  patient  preferences
should  be  prioritized.7
Ideally,  each  team  member’s  opinion  should  be  recorded
in  the  patient’s  medical  record,  together  with  the  final
decision  on  treatment  and  the  patient’s  informed  consent.
Institutional  databases  and  national  registries  (for  acute
coronary  syndrome,  PCI  and  VASP)  should  include  informa-
tion  on  heart  team  interventions  and  their  decisions  in  the
situations  described  below,  as  well  as  the  reasons  when  no
discussion  takes  place.  The  Portuguese  Society  of  Cardiology
is  committed  to  implementing  the  heart  team  approach  in
Left main coronary arte ry with relevant stenosis
±1-vessel disease
Ostium/mid shaft Distal bifurcation
+2- or 3-vessel disease
Syntax score ≤32 Syntax score ≥33
PCI
High
surgical
risk*
High
surgical
risk*
Heart team discussion
CABG
Figure  2  Percutaneous  coronary  intervention  or  coronary
artery  bypass  grafting  in  stable  coronary  artery  disease  with
left main  stenosis.  *  Multidisciplinary  discussion  preferable,  but
direct  decision-making  possible  in  predefined  situations  estab-
lished in  the  local  protocol  by  the  heart  team.  CABG:  coronary
artery  bypass  grafting;  PCI:  percutaneous  coronary  interven-
tion. Reproduced  with  permission  from  the  2013  ESC  Guidelines
on Management  of  Stable  Angina.
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ortugal  and  could  play  an  important  role  in  ensuring  the
esults  are  included  in  national  registries  and  in  promoting
tudies  of  outcomes  before  and  after  the  introduction  of
eart  teams.
linical scenarios in which heart teams should
e involved
eam  decision-making  is  recommended  by  the  ESC  when
hoosing  between  PCI  and  CABG  for  coronary  revasculari-
ation  and  between  surgery  or  TAVI  for  valve  replacement
n  aortic  stenosis.  Other  clinical  situations,  such  as  severe
ymptomatic  mitral  regurgitation  despite  optimized  medi-
al  therapy  in  patients  who  are  unsuitable  or  at  high  risk
or  surgery,  should  also  be  discussed  by  a  heart  team
ith  a view  to  possible  percutaneous  treatment.  Multidis-
iplinary  discussion  should  also  take  place  on  the  treatment
f  heart  failure,  particularly  concerning  the  management  of
omorbidities  and  the  use  of  cardiac  resynchronization  or
mplantable  cardioverter-defibrillator  devices.
oronary  disease
n  coronary  disease,  the  decision-making  process  begins
ith  assessment  of  the  patient’s  coronary  anatomy,  his-
ory  and  comorbidities  that  affect  operative  risk.  The
YNTAX  score,  validated  in  the  study  of  the  same  name,
s  able  to  distinguish  patients  who  will  benefit  from  PCI
nd  those  who  will  benefit  from  CABG.14 Interobserver
ariability  in  calculating  the  score  is  another  reason  for
nterpretation  of  coronary  angiograms  and  calculation  of
he  SYNTAX  score  to  be  carried  out  by  various  heart  team
embers.  The  recently  developed  SYNTAX  score  II com-
ines  two  anatomical  variables  (the  SYNTAX  score  and
resence  of  unprotected  left  main  coronary  artery  dis-
ase)  and  six  clinical  variables  (age,  gender,  creatinine
learance,  ejection  fraction,  chronic  obstructive  pulmonary
isease  and  peripheral  vascular  disease).15 Deciding  the
est  treatment  approach  --  medical  therapy,  PCI  or  CABG
-  should  be  based  on  multidisciplinary  assessment  of  the
natomical  score  (SYNTAX  score)  and  operative  risk,  a
rocess  that  can  be  simplified  by  decision-making  algo-
ithms  (Figures  1  and  2).  Various  risk  scores  have  been
eveloped  to  assess  operative  risk,  the  EuroSCORE  and
TS  score  being  the  most  widely  used.  However,  these
re  merely  tools  to  aid  decision-making  and  cannot  cover
ll  situations  or  replace  assessment  by  a heart  team  and
linical  judgment.  It  is  also  important  in  this  process  to
nform  the  patient  of  the  advantages  and  disadvantages
f  each  therapeutic  option,  using  such  aids  as  diagrams
nd  answers  to  frequently  asked  questions,  as  well  as
nformation  on  the  results  and  experience  of  the  institu-
ion  and  its  physicians.  The  ESC  guidelines  on  myocardial
evascularization  include  tables  defining  the  clinical  and
natomical  characteristics  of  coronary  artery  disease  that
equire  treatment  to  be  delayed  after  diagnosis  to  enable
ultidisciplinary  discussion  and  situations  in  which  it  is  pos-ible  to  perform  ad-hoc  PCI  (Figures  3  and  4).2 Not  all  clinical
ituations  lend  themselves  to  the  timeframe  required  for
ultidisciplinary  consultation,  as  in  ST-elevation  myocar-
ial  infarction  (Figure  3).  In  other  cases,  particularly  stable
48  M.  Sousa  Uva  et  al.
Shock
Not mandatory.Multidisciplinary
decision making
Informed consen t Oral witnessed
informed consent
or family consent
if possible without
delay.
Oral witnessed
informed consent
may be sufficient
unless written
consent is legally
required.
Written informed
consent (if time
permits).
Written informed
consent
Written informed
consent
Written informed
consent
Not mandatory. Not required for
culprit lesion  but
required for non-
culprit  vessel(s).
Required. Required. According to
predefined
protocols.
ACS
STEMI NSTE - ACS Other -  ACS
Stable MVD
Stable with
indication for ad
hoc PCI
Figure  3  Multidisciplinary  decision  pathways,  patient  informed  consent,  and  timing  of  intervention.  ACS:  acute  coronary  syn-
drome; MVD:  multivessel  disease;  PCI:  percutaneous  coronary  intervention;  STEMI:  ST-elevation  myocardial  infarction;  NSTE-ACS:
non-ST elevation  acute  coronary  syndrome.  Reproduced  with  permission  from  the  2010  ESC-EACTS  Guidelines  on  Myocardial  Revas-
cularization.
angina  with  left  main  or  three-vessel  disease  involving  the
anterior  descending  artery,  an  interval  is  recommended
following  coronary  angiography  to  enable  the  patient  to
be  informed  and  the  case  discussed  by  the  heart  team
(Figure  4).
Severe  aortic  stenosis  in  patients  at  high  surgical
risk
Aortic  valve  replacement  is  a  class  IA  recommendation
for  symptomatic  severe  aortic  stenosis  in  the  2012  ESC
guidelines.  Surgical  valve  replacement  should  be  considered
except  in  patients  with  contraindications  to  surgery  or  high
surgical  risk;  in  such  cases,  TAVI  should  be  discussed.  The
Haemodynamically unstable patients (including cardiogenic shock).
Non-recurrent restenotic lesions.
Lesions with high-risk morphology.
Chronic heart  failure.
Renal failure (creatinine clearance <60 mL/min), if total contrast
volume required >4 mL/kg.
Stable patients with MVD including LAD invol vement.
Stable patients with ostial or complex proximal LAD lesion.
Any clinical or angiographic evidence of higher periprocedural risk 
with ad hoc PCI.
Revascula rization at an inte rval
Ad hoc PCI 
Culprit lesion in STEMI and NSTE-ACS.
Stable low- risk patients with single or double vessel disease 
(proximal LAD excluded) and favou rable morphology 
(RCA, non-ostial LCx, Mid-or distal LAD).
Figure  4  Indications  for  ad  hoc  percutaneous  coronary  inter-
vention or  revascularization  at  an  interval.  LAD:  left  anterior
descending;  LCx:  left  circumflex;  MVD:  multivessel  disease;
STEMI:  ST-elevation  myocardial  infarction;  NSTE-ACS:  non-ST
elevation  acute  coronary  syndrome;  PCI:  percutaneous  coro-
nary intervention;  RCA:  right  coronary  artery.  Reproduced  with
permission  from  the  2010  ESC-EACTS  Guidelines  on  Myocardial
Revascularization.
suggested  algorithm  indicates  that  the  decision  should  be
taken  by  a  heart  team  (Figure  5).3
TAVI  should  be  performed  only  in  hospitals  with  on-site
cardiac  surgery.  The  heart  team  should  assess  comorbidi-
ties,  surgical  risk,  the  technical  feasibility  of  TAVI  and  the
patient’s  life  expectancy,  as  well  as  identifying  cases  in
which  the  procedure  is  likely  to  improve  quality  of  life.
TAVI  may  be  indicated  in  patients  who  are  unsuitable  for
surgery  due  to  severe  comorbidities  or  for  technical  reasons.
Contraindication
for AVR
seYoN
Symptomatic s evere ao rtic stenosis
No Yes
No
AVR
Yes
TAVI
AVR or  TAVI
Med Rx
High  risk
for  AVR
Short life
expectancy
Heart team
Heart team
Figure  5  Decision-making  algorithm  for  symptomatic  severe
aortic  stenosis.  AVR:  aortic  valve  replacement;  Med  Rx:  medical
therapy;  TAVI:  transcatheter  aortic  valve  implantation.  Modified
from the  2012  ESC  Guidelines  on  the  Management  of  Valvular
Heart  Disease.
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In  patients  with  high  surgical  risk  but  who  are  operable,
the  decision  between  surgical  valve  replacement  and  TAVI
should  be  on  a  case-by-case  basis,  taking  account  of  the
advantages  and  disadvantages  of  each  method.  The  decision
should  be  based  on  clinical  assessment  by  the  heart  team
aided  by  risk  scores  (EuroSCORE  and  STS  score),  bearing  in
mind  that  these  scores  have  significant  limitations  as  they
do  not  include  important  risk  factors  such  as  neurocognitive
dysfunction,  decreased  mobility  and  frailty,  and  should  not
be  used  in  isolation.
Checklist
Every  institution  involved  in  the  medical  and  surgical  treat-
ment  of  patients  with  coronary  artery  or  valve  disease  should
have  a  checklist  that  includes  the  following:
(1)  Situations  in  which  the  heart  team  should  be  consulted;
(2)  Reasons  for  not  consulting  the  heart  team;
(3)  Reasons  for  recommending  a  particular  approach:  medi-
cal  therapy,  percutaneous  treatment  or  surgery;
(4)  Decision  of  the  heart  team;
(5)  Informed  consent  signed  by  the  patient  and  members  of
the  heart  team.
Attached  to  this  document  there  should  be  an  informa-
tion  sheet  for  the  patient,  prepared  by  the  heart  team,
describing  the  medical,  percutaneous  and  surgical  options
in  plain  language,  including  the  advantages  and  disadvan-
tages  of  each  in  terms  of  physical  discomfort,  functional
limitations,  potential  complications,  possible  need  for  rein-
tervention  and  long-term  outcomes.
Conclusion
Heart  teams  bring  several  benefits  for  patients  and  for
society  at  large:  better  adherence  to  guidelines,  less  risk
of  inappropriate  indications,  more  comprehensive  and  bal-
anced  information,  reduced  variability  in  patient  care,
better  overall  understanding  of  patients’  values  and  prefer-
ences,  and  less  risk  of  malpractice.
Establishing  heart  teams  will  require  the  commitment
and  concerted  efforts  of  physicians  who  are  aware  of  the
potential  benefits  and  are  determined  to  overcome  existing
obstacles.  However,  the  support  of  medical  societies,  pro-
ducing  guidelines  and  providing  a  registry  platform,  together
with  encouragement  from  health  authorities,  are  all  factors
that  can  facilitate  this  process.  Hopefully,  in  the  not  too
distant  future,  cardiology  and  cardiothoracic  surgery  soci-
eties  will  collaborate  more  closely,  coordinating  educational
initiatives,  disease  and  intervention  registries,  outcome
analysis  and  certification.  Interdisciplinary  cooperation  and
shared  decision-making  will  play  an  increasingly  important
role  in  modern  societies  faced  with  the  need  to  optimize
health  care.
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